))
Transforming Sleep Health Through AI-Personalized Therapy with Morgan Moncada
Manage episode 436283620 series 2546725
内容由Mike Biselli提供。所有播客内容（包括剧集、图形和播客描述）均由 Mike Biselli 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE
---
Episode Overview:
How can we combat the growing epidemic of chronic sleep disorders?
Our next guest, Morgan Moncada, has a vision to transform sleep health through AI-personalized therapy.
As CEO and co-founder of Neru Health, Morgan is tackling this challenge head-on, starting with the 20+ million shift workers whose sleep struggles cost employers over $100 billion annually.
Drawing from his own experiences and a decade of life science entrepreneurship, Morgan is developing groundbreaking solutions to improve workforce productivity, safety, mental health, and cardiometabolic wellbeing.
Join us as Morgan shares Neru Health's pioneering approach to democratizing access to personalized sleep care and elevating sleep as a critical pillar of holistic health and wellness. Let’s go!
Episode Highlights:
- Morgan's personal journey with sleep issues inspired his mission to tackle this critical health challenge.
- Neru Health's AI-personalized approach addresses the complexities of sleep disorders.
- Shift workers represent a $100B market opportunity for Neru Health's solutions.
- Neru's tech can reduce medical errors in night shift nurses by 60% and trucking accidents.
- Morgan invites the community to test Neru's AI system and connect the company with potential partners.
About our Guest:
Morgan Moncada is CEO and co-founder of Neru Health. His passion for sleep health began with his own challenges overcoming insomnia and sleep apnea while also witnessing his family members who are shift workers struggle with sleep for years. Morgan has more than a decade of life science entrepreneurship and investing experience, ranging from antibody therapeutics to a synthetic biology nose-on-a-chip technology. He is currently completing his Harvard Blavatnik Life Science Fellowship working in Neru. Morgan earned his MBA and MS Biotechnology from Harvard University and his B.S. Biology from Stanford University.
Links Supporting This Episode:
- Neru Health Website: CLICK HERE
- Morgan Moncada LinkedIn page: CLICK HERE
- Neru Health LinkedIn page: CLICK HERE
- Mike Biselli LinkedIn page: CLICK HERE
- Mike Biselli Twitter page: CLICK HERE
- Visit our website: CLICK HERE
- Subscribe to newsletter: CLICK HERE
- Guest nomination form: CLICK HERE
296集单集
分享
